Skip to main content
×
Home
    • Aa
    • Aa

Fragment-based approaches to TB drugs

  • CHIARA MARCHETTI (a1), DANIEL S. H. CHAN (a1), ANTHONY G. COYNE (a1) and CHRIS ABELL (a1)
Abstract
SUMMARY

Tuberculosis is an infectious disease associated with significant mortality and morbidity worldwide, particularly in developing countries. The rise of antibiotic resistance in Mycobacterium tuberculosis (Mtb) urgently demands the development of new drug leads to tackle resistant strains. Fragment-based methods have recently emerged at the forefront of pharmaceutical development as a means to generate more effective lead structures, via the identification of fragment molecules that form weak but high quality interactions with the target biomolecule and subsequent fragment optimization. This review highlights a number of novel inhibitors of Mtb targets that have been developed through fragment-based approaches in recent years.

Copyright
Corresponding author
*Corresponding author: Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. E-mail: ca26@cam.ac.uk; agc40@cam.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

L. G. Dover , P. E. Corsino , I. R. Daniels , I. R. Cocklin , V. Tatituri , G. S. Besra and K. Fütterer (2004). Crystal Structure of the TetR/CamR Family Repressor Mycobacterium tuberculosis EthR Implicated in Ethionamide Resistance. Journal of Molecular Biology 340, 10951105.

K. Hotta , T. Kitahara and Y. Okami (1975). Studies on the mode of action of amiclenomycin. Journal of Antibiotics 28, 222228.

S. A. Hudson , K. J. McLean , A. W. Munro and C. Abell (2012 a). Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets. Biochemical Society Transactions 40(3), 573579.

S. A. Hudson , S. Surade , A. G. Coyne , K. J. McLean , D. Leys , A. W. Munro and C. Abell (2013). Overcoming the limitations of fragment merging: rescuing a strained merged fragment series targeting Mycobacterium tuberculosis CYP121. ChemMedChem 8, 14511456.

M. Jackson , C. Raynaud , M. A. Lanéelle , C. Guilhot , C. Laurent-Winter , D. Ensergueix , B. Gicquel and M. Daffé (1999). Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Molecular Microbiology 31, 15731587.

A. Koul , E. Arnoult , N. Lounis , J. Guillemont and K. Andries (2011). The challenge for new drug discovery for tuberculosis. Nature 469, 483490.

E. Mashalidis , P. Śledź , S. Lang and C. Abell (2013). A three-stage biophysical screening cascade for fragment-based drug discovery. Nature Protocols 8, 23092324.

V. K. Sambandamurthy , X. Wang , B. Chen , R. G. Russell , S. Derrick , F. M. Collins , S. L. Morris and W. R. Jacobs (2002). A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nature Medicine 8, 11711174.

M. F. Schmidt , M. R. Groves and J. Rademann (2011). Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases. ChemBioChem 12, 26402646.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Parasitology
  • ISSN: 0031-1820
  • EISSN: 1469-8161
  • URL: /core/journals/parasitology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 16
Total number of PDF views: 101 *
Loading metrics...

Abstract views

Total abstract views: 368 *
Loading metrics...

* Views captured on Cambridge Core between 2nd November 2016 - 28th March 2017. This data will be updated every 24 hours.